These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 26387181

  • 1. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
    Zhang YY, Tian WP, Mei M.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
    [Abstract] [Full Text] [Related]

  • 2. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.
    Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, Lu Z, Gao S, Liao Y, Chen B, Yu F.
    FEBS J; 2014 Jan; 281(1):88-103. PubMed ID: 24138392
    [Abstract] [Full Text] [Related]

  • 3. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D, Deb M, Rath SK, Kar S, Parbin S, Pradhan N, Patra SK.
    Exp Cell Res; 2016 Aug 15; 346(2):176-87. PubMed ID: 27475839
    [Abstract] [Full Text] [Related]

  • 4. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L, Brown I, Schofield AC.
    Int J Oncol; 2010 May 15; 36(5):1235-41. PubMed ID: 20372798
    [Abstract] [Full Text] [Related]

  • 5. M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development.
    Ma D, Wu J, Chen C, Niu Y, Ji K, Xiao Y, Guan Q.
    Biochem Genet; 2024 Jun 15; 62(3):2082-2099. PubMed ID: 37851210
    [Abstract] [Full Text] [Related]

  • 6. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov 15; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 7. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
    Liu J, Pang Y, Wang H, Li Y, Sun X, Xu F, Ren H, Liu D.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar 15; 32(3):299-303. PubMed ID: 26927545
    [Abstract] [Full Text] [Related]

  • 8. Impact of miRNAs expression modulation on the methylation status of breast cancer stem cell-related genes.
    El-Osaily HH, Ibrahim IH, Essawi ML, Salem SM.
    Clin Transl Oncol; 2021 Jul 15; 23(7):1440-1451. PubMed ID: 33433838
    [Abstract] [Full Text] [Related]

  • 9. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT, Kim SK, Lim SC, Kim HS, Kim TH, Lee KY, Ahn SG, Yoon JH, Kang KW.
    Breast Cancer Res Treat; 2011 Nov 15; 130(1):73-83. PubMed ID: 21170675
    [Abstract] [Full Text] [Related]

  • 10. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.
    Li G, Zhao J, Peng X, Liang J, Deng X, Chen Y.
    Biochem Biophys Res Commun; 2012 Feb 17; 418(3):547-52. PubMed ID: 22290228
    [Abstract] [Full Text] [Related]

  • 11. Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway.
    Kumar P, Raeman R, Chopyk DM, Smith T, Verma K, Liu Y, Anania FA.
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct 17; 1864(10):3537-3545. PubMed ID: 30293572
    [Abstract] [Full Text] [Related]

  • 12. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
    Peng X, Chang H, Chen J, Zhang Q, Yu X, Mi M.
    BMC Cancer; 2017 Sep 05; 17(1):619. PubMed ID: 28870206
    [Abstract] [Full Text] [Related]

  • 13. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N, Miao Y, Shan Y, Liu B, Li Y, Zhao L, Jia L.
    Cell Death Dis; 2017 May 18; 8(5):e2796. PubMed ID: 28518139
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation.
    Huang S, Li XQ, Chen X, Che SM, Chen W, Zhang XZ.
    Dis Esophagus; 2013 May 18; 26(8):823-31. PubMed ID: 22958183
    [Abstract] [Full Text] [Related]

  • 15. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
    De Blasio A, Di Fiore R, Pratelli G, Drago-Ferrante R, Saliba C, Baldacchino S, Grech G, Scerri C, Vento R, Tesoriere G.
    J Cell Physiol; 2020 Feb 18; 235(2):629-637. PubMed ID: 31313842
    [Abstract] [Full Text] [Related]

  • 16. miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.
    Li W, Yi J, Zheng X, Liu S, Fu W, Ren L, Li L, Hoon DSB, Wang J, Du G.
    Clin Epigenetics; 2018 Feb 18; 10():64. PubMed ID: 29796115
    [Abstract] [Full Text] [Related]

  • 17. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S, Li W, Chen Z, Xu J, Zhao J.
    Gene; 2013 Nov 15; 531(1):8-14. PubMed ID: 23994196
    [Abstract] [Full Text] [Related]

  • 18. [Effect of DNA methylation on the proliferation of leukemia cells regulated by miR-34b].
    Cao L, Wang N, Pan J, Gu G, Hu S, Zhao W, Chai Y.
    Zhonghua Er Ke Za Zhi; 2014 Nov 15; 52(11):840-5. PubMed ID: 25582471
    [Abstract] [Full Text] [Related]

  • 19. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
    Robaina MC, Mazzoccoli L, Arruda VO, Reis FR, Apa AG, de Rezende LM, Klumb CE.
    Exp Mol Pathol; 2015 Apr 15; 98(2):200-7. PubMed ID: 25746661
    [Abstract] [Full Text] [Related]

  • 20. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H, Wang D, Li L, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J.
    Gene; 2017 Jan 05; 596():110-118. PubMed ID: 27746366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.